product summary
Loading...
company name :
Bio-Rad
other brands :
Biogenesis, Serotec, AbD Serotec, Oxford Biotechnology
product type :
antibody
product name :
Mouse anti Herpes simplex Virus 1 VP21/VP22a
catalog :
MCA406
quantity :
1 mg
price :
660 USD
clonality :
monoclonal
host :
mouse
conjugate :
nonconjugated
clone name :
LP13
reactivity :
Herpes simplex virus type 1
application :
western blot, immunocytochemistry, immunoprecipitation
more info or order :
Bio-Rad product webpage
citations: 9
Published Application/Species/Sample/DilutionReference
  • immunocytochemistry; Herpes simplex virus type 1; 1:500; fig 8
Albright B, Kosinski A, Szczepaniak R, Cook E, Stow N, Conway J, et al. The putative herpes simplex virus 1 chaperone protein UL32 modulates disulfide bond formation during infection. J Virol. 2015;89:443-53 pubmed publisher
  • western blot; Herpes simplex virus type 1; 1:1000
Maric M, Haugo A, Dauer W, Johnson D, Roller R. Nuclear envelope breakdown induced by herpes simplex virus type 1 involves the activity of viral fusion proteins. Virology. 2014;460-461:128-37 pubmed publisher
Yang K, Wills E, Lim H, Zhou Z, Baines J. Association of herpes simplex virus pUL31 with capsid vertices and components of the capsid vertex-specific complex. J Virol. 2014;88:3815-25 pubmed publisher
Yang K, Wills E, Baines J. Release of the herpes simplex virus 1 protease by self cleavage is required for proper conformation of the portal vertex. Virology. 2012;429:63-73 pubmed publisher
Yang K, Baines J. Tryptophan residues in the portal protein of herpes simplex virus 1 critical to the interaction with scaffold proteins and incorporation of the portal into capsids. J Virol. 2009;83:11726-33 pubmed publisher
Yang K, Baines J. Domain within herpes simplex virus 1 scaffold proteins required for interaction with portal protein in infected cells and incorporation of the portal vertex into capsids. J Virol. 2008;82:5021-30 pubmed publisher
Meckes D, Wills J. Dynamic interactions of the UL16 tegument protein with the capsid of herpes simplex virus. J Virol. 2007;81:13028-36 pubmed
Yang K, Homa F, Baines J. Putative terminase subunits of herpes simplex virus 1 form a complex in the cytoplasm and interact with portal protein in the nucleus. J Virol. 2007;81:6419-33 pubmed
Newcomb W, Homa F, Brown J. Herpes simplex virus capsid structure: DNA packaging protein UL25 is located on the external surface of the capsid near the vertices. J Virol. 2006;80:6286-94 pubmed
product information
Entity Type :
Monoclonal Antibody
Entity Category :
Antibodies
ProductCode :
MCA406
Description :
Mouse anti Herpes simplex Virus 1 VP21/VP22a
Specificity :
Herpes simplex Virus 1 VP21/VP22a
TargetSpecies :
Viral
Host :
Mouse
Format :
Purified
Isotypes :
IgG2a
Applications :
WB,IF,IP,EM
ApplicationTypes :
Western Blotting,Immunofluorescence,Immunoprecipitation,Immuno-electron Microscopy
Clone :
LP13
Quantity :
1 mg
Quantity Value :
1
Quantity Type :
mg
Entity Formats :
Purified
UNSPSC :
41116161
Concentration :
IgG concentration 1.0 mg/ml
Product Form :
Purified IgG - liquid
PriceGBP :
471
PriceEUR :
660
PriceUSD :
660 USD
PriceCHF :
718
PriceSEK :
7194
PriceNOK :
7230
PriceDKK :
4921
NotForSaleInCountries :
AU
more info or order :
Bio-Rad product webpage
company information
Bio-Rad
Endeavour House, Langford Business Park
Langford Lane, Kidlington
OXON, OX5 1GE
antibody_sales_uk@bio-rad.com
https://www.bio-rad-antibodies.com
1 800 265 7376 (North America)
44 (0)1865 852 700 (Rest of World)
headquarters: UK
Bio-Rad is one of the world's leading antibody manufacturers, offering over 12,000 antibodies and related reagents for a focused range of research areas such as immunology, cancer, veterinary research and cell biology through its antibody experts formerly known as AbD Serotec.
The range includes apoptosis kits, autophagy reagents, CD markers, epitope tag antibodies, immunology antibodies, neuroscience antibodies, and veterinary reagents.
Bio-Rad has an ISO 9001 and ISO 13485 certified production facility in the United Kingdom as well as ISO 9001 certified facilities in Germany and the United States.
Our expertise extends to traditional and recombinant antibody generation and production services. Our custom generation service delivers antibodies in as little as 8 weeks with greater than 90% success. The in vitro technology enables selection of antibodies to challenging targets, long term consistent supply, and provision of the antibody sequence.
At Bio-Rad we are committed to your success when using our antibodies and we focus on providing the technology, products and all the supporting information you need to excel in your research.